Clinical Trials Browser

Phase 1/2 × vitespin × Clear all

NCT00293423 2021-05-13

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma

Phase 1/2 Completed

96 enrolled 19 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms

NCT02452281 2016-01-25

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Phase 1/2 Withdrawn

Melanoma